Akso Health Financials
| AHG Stock | USD 0.80 0.05 5.88% |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Debt Equity Ratio | 0.0137 | 0.0145 |
|
| |||||
| Current Ratio | 41.49 | 39.5162 |
|
|
Investors should never underestimate Akso Health's ability to pay suppliers on time, ensure interest payments are not accumulating, and correctly time where and how to reinvest extra cash. Individual investors need to monitor Akso Health's cash flow, debt, and profitability to make informed and accurate decisions about investing in Akso Health Group.
Net Income |
|
Akso | Select Account or Indicator |
Understanding current and past Akso Health Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Akso Health's financial statements are interrelated, with each one affecting the others. For example, an increase in Akso Health's assets may result in an increase in income on the income statement.
Akso Health Stock Summary
Akso Health competes with Henry Schein, Owens Minor, Cardinal Health, Zynex, and McKesson. Akso Health Group operates a social e-commerce mobile platform in China. As of July 13, 2021, Akso Health Group operates as a subsidiary of Webao Limited. Akso Health operates under Credit Services classification in the United States and is traded on NASDAQ Exchange. It employs 113 people.Specialization | Health Care, Health Care Equipment & Services |
| Instrument | USA Stock View All |
| Exchange | NASDAQ Exchange |
| ISIN | US98422P1084 |
| CUSIP | 428295109 98422P108 428295208 |
| Location | China |
| Business Address | Qiantongyuan Building, Qingdao, |
| Sector | Health Care Equipment & Supplies |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.ahgtop.com |
| Phone | 86 15 2100 54919 |
| Currency | USD - US Dollar |
Akso Health Key Financial Ratios
| Return On Equity | -0.12 | ||||
| Operating Margin | (4.16) % | ||||
| Price To Sales | 130.45 X | ||||
| Revenue | 2.41 M | ||||
| Gross Profit | 1.27 M |
Akso Health Key Balance Sheet Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Total Assets | 78.4M | 31.7M | 50.7M | 20.5M | 142.0M | 86.9M | |
| Other Current Liab | 9.3M | 4.1M | 38.4M | 1.8M | 1.1M | 1.0M | |
| Net Debt | 9.9M | (5.1M) | (21.9M) | 1.8M | (85.2M) | (80.9M) | |
| Retained Earnings | (1.4M) | (36.3M) | (53.1M) | (54.5M) | (63.9M) | (60.7M) | |
| Cash | 10.9M | 15.1M | 21.9M | 7.9M | 85.2M | 43.8M | |
| Net Receivables | 37.8M | 10.4M | 20.0M | 7.7M | 56.3M | 59.1M | |
| Other Current Assets | 39.0B | 592.8K | 885.9K | 3.4M | 56.7M | 53.8M | |
| Total Liab | 30.3M | 14.4M | 38.4M | 11.6M | 3.6M | 3.4M | |
| Total Current Assets | 49.9M | 30.1M | 50.6M | 20.7M | 142.0M | 72.4M | |
| Common Stock | 5.0K | 5.0K | 5.0K | 7.0K | 43.8K | 46.0K | |
| Net Tangible Assets | 48.1M | 17.3M | 12.3M | 8.7M | 7.9M | 7.5M | |
| Net Invested Capital | 68.1M | 27.3M | 12.3M | 8.7M | 138.4M | 145.3M | |
| Net Working Capital | 39.8M | 15.7M | 12.2M | 9.1M | 138.4M | 145.3M | |
| Inventory | (39.0B) | (14.4M) | 7.8M | 1.7M | 191.2K | 200.8K |
Akso Health Key Income Statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Total Revenue | 11.4M | 1.8M | 6.3M | 13.2M | 2.4M | 2.3M | |
| Gross Profit | 6.4M | 1.2M | 916.2K | 1.3M | 122.1K | 116.0K | |
| Operating Income | (36.8M) | (27.1M) | (15.1M) | (14.3M) | (8.6M) | (8.2M) | |
| Ebit | (36.8M) | (2.1M) | (15.1M) | (14.3M) | (8.6M) | (8.2M) | |
| Research Development | 1.0M | 544.6K | 421.2K | (0.99) | 3.76 | 3.57 | |
| Ebitda | (34.6M) | (2.1M) | (15.9M) | (14.2M) | (8.5M) | (8.1M) | |
| Cost Of Revenue | 5.0M | 544.6K | 5.4M | 11.9M | 2.3M | 2.2M | |
| Income Before Tax | (66.9M) | (31.1M) | (16.7M) | (13.1M) | (9.1M) | (8.6M) | |
| Net Income | (71.2M) | (31.6M) | (16.8M) | (13.1M) | (9.5M) | (9.9M) | |
| Income Tax Expense | 4.3M | 483.0K | 131.4K | 17.5K | 25.0K | 23.7K | |
| Tax Provision | 4.3M | 483.0K | 131.4K | 17.5K | 25.0K | 23.7K |
Akso Health Key Cash Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change In Cash | (46.4M) | 4.2M | 6.8M | (12.7M) | 77.0M | 80.9M | |
| Free Cash Flow | (56.2M) | 10.1M | (8.6M) | (3.3M) | 1.4M | 1.3M | |
| Depreciation | 406.8K | 580.5K | 15.2K | 18.4K | 21.1K | 20.1K | |
| Net Income | (71.2M) | (34.7M) | (16.8M) | (13.1M) | (9.1M) | (9.6M) | |
| End Period Cash Flow | 10.9M | 15.1M | 21.9M | 9.2M | 86.2M | 90.5M | |
| Investments | (14.6M) | (662.0) | (20.0M) | 18.5M | (54.7M) | (52.0M) | |
| Net Borrowings | (6.7M) | (9.1M) | 24.8M | (27.5M) | (24.8M) | (23.5M) | |
| Other Non Cash Items | (3.5B) | (3.2M) | 10.4M | 11.0M | 8.4M | 8.0M | |
| Change To Netincome | 44.9M | 23.8M | 10.8M | (720.3K) | (828.4K) | (787.0K) |
Akso Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Akso Health's current stock value. Our valuation model uses many indicators to compare Akso Health value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Akso Health competition to find correlations between indicators driving Akso Health's intrinsic value. More Info.Akso Health Group is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . At this time, Akso Health's Return On Equity is most likely to slightly decrease in the upcoming years. Comparative valuation analysis is a catch-all technique that is used if you cannot value Akso Health by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Akso Health Group Systematic Risk
Akso Health's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Akso Health volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Beta measures systematic risk based on how returns on Akso Health Group correlated with the market. If Beta is less than 0 Akso Health generally moves in the opposite direction as compared to the market. If Akso Health Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Akso Health Group is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Akso Health is generally in the same direction as the market. If Beta > 1 Akso Health moves generally in the same direction as, but more than the movement of the benchmark.
About Akso Health Financials
What exactly are Akso Health Financials? Typically, a company's financial statements are the reports that show the financial position of the company. Three primary documents fall into the category of financial statements. These documents include Akso Health's income statement, its balance sheet, and the statement of cash flows. Potential Akso Health investors and stakeholders use financial statements to determine how well the company is positioned to perform in the future. Although Akso Health investors may use each financial statement separately, they are all related. The changes in Akso Health's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Akso Health's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.Akso Health Thematic Clasifications
Akso Health Group is part of Drugs investing theme. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. Drug manufacturing and delivery. Companies involved in medical and pharmaceutical drug research, manufacturing, and delivery
This theme covers Drug manufacturing and delivery. Companies involved in medical and pharmaceutical drug research, manufacturing, and delivery. Get More Thematic Ideas
| Drugs | View |
Today, most investors in Akso Health Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Akso Health's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Akso Health growth as a starting point in their analysis.
Price Earnings To Growth Ratio |
|
Akso Health November 29, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Akso Health help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Akso Health Group. We use our internally-developed statistical techniques to arrive at the intrinsic value of Akso Health Group based on widely used predictive technical indicators. In general, we focus on analyzing Akso Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Akso Health's daily price indicators and compare them against related drivers.
| Information Ratio | (0.02) | |||
| Maximum Drawdown | 65.29 | |||
| Value At Risk | (10.00) | |||
| Potential Upside | 7.87 |
Complementary Tools for Akso Stock analysis
When running Akso Health's price analysis, check to measure Akso Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Akso Health is operating at the current time. Most of Akso Health's value examination focuses on studying past and present price action to predict the probability of Akso Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Akso Health's price. Additionally, you may evaluate how the addition of Akso Health to your portfolios can decrease your overall portfolio volatility.
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data |